Search Clinical Trials
Home > Clinical Trials & Research > Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title Principal Investigator Post Date
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients Kris Mahadeo, MD   
Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH) Nicole Sutton, MD   
Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ IDE Clinical Study Protocol Ulrich Jorde, MD   
9925 Phase II Trial of Nivolumab for HTLV-Associated Adult T Cell Leukemia/Lymphoma Murali Janakiram   
A 24 Week, Multicenter, Randomized, Double-Blind, Parallel Group, Phase 3 Trial with a 28 Week Long Term Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 10 mg in T2DM Patients aged 10-24 years. Rubina Heptulla   
A 52 week, open label evaluation of the effects of sacubitril/valsartan (LCZ696) therapy on biomarkers, myocardial remodeling and patient-reported outcomes in heart failure with reduced left ventricular ejection fraction (PROVE-HF) Sandhya Murthy   
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions. Anna Bortnick, MD, PhD   
A Decision Aid with HRQL Assessment to Reduce Costs in the Treatment of NSCLC Richard Gralla   
A Double Blind, Randomized, Placebo Controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy on LDL-C of Evolocumab (AMG 145) in Subjects with HIV and with Hyperlipidemia and/or Mixed Dyslipidemia Robert Grossberg   
A Double Blind, Randomized, Placebo-Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin (FCT) Eric Hollander, MD   
A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension Nicole Sutton   
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of Xyrem with an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects with Narcolepsy with Cataplexy Michael Thorpy   
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence Nitya Abraham, MD   
A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer (PACIFIC) Missak Haigentz, MD   
A Global Study to Assess the Effects of MEDI4736 in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer (ATLANTIC) Missak Haigentz, MD   
A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer (ARCTIC) Missak Haigentz, MD   
A Long-Term, Open-Label Safety and Maintenance of Efficacy Study of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or Obstructive Sleep Apnea Michael Thorpy, MD   
A Multi-arm Phase 3 Randomized Placebo Controlled Double Blind Clinical Trial to Investigate the Efficacy and Safety of BMS-663068 in Heavily Treatment Experienced Subjects Infected With Multi-drug Resistant HIV-1 Robert Grossberg, MD   
A Multi-Center, Randomized, Placebo Controlled, Double-Blind Study to Confirm Efficacy and Safety of Terlipressin in Subjects With Hepatorenal Syndrome Type 1 (The CONFIRM Study) Samuel Sigal, MD   
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications Kris Mahadeo, MD   
A multicenter open label uncontrolled study of the long term safety and efficacy of calcitriol 3 mcg/g ointment applied twice daily for 26 weeks in pediatric subjects (2 to 16 years and 11 months of age) with mild to moderate plaque psoriasis Holly Kanavy   
A Multicenter Open-Label Phase 2a Study of Ibrutinib With or Without Cytarabine in Subjects With Acute Myeloid Leukemia Ioannis Mantzaris, MD   
A Multicenter Single-arm Extension Study to Characterize the Long-term Safety of Cinacalcet Hydrochloride in the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects With Chronic Kidney Disease on Dialysis Anna Zolotnitskaya, MD   
A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy Michael Thorpy, MD    
A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304 Kris Mahadeo, MD   
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan (IDN-6556), an Oral Caspase Inhibitor, in Subjects with Non-alcoholic Steatohepatitis (NASH) Fibrosis Harmit Kalia   
A Phase 1 Study of LY3039478 in Patients With Advanced or Metastatic Cancer Sanjay Goel   
A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors Sanjay Goel, MD   
A Phase 1 Study of MEDI4736 (Anti-PD-L1 Antibody) inCombination with Tremelimumab (Anti-CTLA-4 Antibody)in Subjects with Advanced Solid Tumors Sanjay Goel   
A Phase 1, Open-label, Dose-escalation Study of SEA-CD40 in Adult Patients With Advanced Malignancies Sanjay Goel, MD   
A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) (ZUMA-1) Ira Braunschweig, MD   
A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies Sanjay Goel   
A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies Sanjay Goel, MD   
A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer Missak Haigentz, MD   
A Phase 1b/Randomized Phase 2 Study to Evaluate LY3039478 in Combination With Dexamethasone in T-ALL/T-LBL Patients Murali Janakiram   
A Phase 2 Study of MM-121 in Combination With Docetaxel or Pemetrexed Versus Docetaxel or Pemetrexed Alone in Patients With Heregulin Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Haiying Cheng   
A Phase 2 Study of MM-121 in Combination With Docetaxel or Pemetrexed Versus Docetaxel or Pemetrexed Alone in Patients With Heregulin Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Haiying Cheng, MD   
A Phase 2, Multi-Center, Open Label, Simon Two-Stage Study to Evaluate the Safety and Efficacy of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia Irina Murakhovskaya   
A Phase 2a Randomized, Open-label Study to Assess the Safety, Tolerability, and Efficacy of BAX69 in Combination With 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer Sanjay Goel   
A Phase 2a, Multicenter, Randomized, Double-blind, Placebocontrolled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of V120083 in Subjects with Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee Naum Shaparin   
A Phase 2b/3 Prospective, Randomized, Double-Blind, Sham-Controlled Trial of VTS-270 (2-hydroxypropyl---cyclodextrin) in Subjects with Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease Paul Levy   
A Phase 3 Multicenter Open-label Study of Brigatinib(AP26113) versus Crizotinib in Patients with ALK-positiveAdvanced Lung Cancer Balazs Halmos   
A Phase 3 Multicenter Trial Evaluating theEfficacy and Safety of MitoGel- on Ablation ofUpper Urinary Tract Urothelial Carcinoma Joshua Stern   
A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) Benjamin Gartrell, MD    
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (ATHOS-3) Michelle Gong, MD   
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadaquate Glycemic Control With Insulin Therapy Alone (inTandem3) Rubina Heptulla, MD   
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis Samuel Sigal   
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis Samuel Sigal, MD   
A PHASE 3, PLACEBO CONTROLLED, DOUBLE-BLIND, RANDOMIZED, CLINICAL STUDY TO DETERMINE EFFICACY, SAFETY AND TOLERABILITY OF PULSED, INHALED NITRIC OXIDE (iNO) VERSUS PLACEBO IN SYMPTOMATIC SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) INOvation-1 Ali Zaidi   
A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant Deepa Manwani   
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC-3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia Paul Riska   
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) Samuel Sigal   
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis Samuel Sigal   
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF MONGERSEN (GED-0301) FOR THE TREATMENT OF SUBJECTS WITH ACTIVE CROHN-S DISEASE Dana Lukin   
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes Rubina Heptulla   
A PHASE 3, RANDOMIZED, MULTICENTER, SINGLE-BLIND CONTROLLED STUDY EVALUATING ARTERIOVENOUS FISTULA OUTCOMES WITH AND WITHOUT A PERIVASCULAR SIROLIMUS-ELUTING COLLAGEN IMPLANT IN SUBJECTS ON HEMODIALYSIS (THE ACCESS TRIAL) Larry Scher   
A Phase 3, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus-Eluting Collagen Implant in Subjects on Hemodialysis Larry Scher, MD   
A Phase 3, Randomized, Open-Label, Active-Controlled Study of ALXN1210 Versus Eculizumab in Complement Inhibitor-Na-ve Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Irina Murakhovskaya   
A Phase 4 Trial Assessing the Impact of Residual Inflammation Detected via Imaging Techniques, Drug Levels and Patient Characteristics on the Outcome of Dose Tapering of Adalimumab in Clinical Remission Rheumatoid Arthritis (RA) Subjects (PREDICTRA) Clement Tagoe   
A phase I open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK2879552 given orally in subjects withrelapsed/refractory acute myeloid leukemia Amit Verma   
A Phase I/IIa, Open-label, Dose-escalation Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients with Advanced Malignancy Sanjay Goel   
A PHASE Ib/II, OPEN-LABEL STUDY OF THESAFETY AND PHARMACOLOGY OFATEZOLIZUMAB ADMINISTERED WITH ORWITHOUT BACILLE CALMETTE-GU-RIN INPATIENTS WITH HIGH-RISK NON-MUSCLE-INVASIVEBLADDER CANCER Alexander I. Sankin   
A Phase II Study of Pembrolizumab (MK-3475) as Monotherapy in Subjects with Previously Systemically Treated Advanced Hepatocellular Carcinoma (KEYNOTE-224) Andreas Kaubisch   
A Phase II Trial of Preoperative FOLFIRINOX Followed by Gemcitabine Based Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Adenocarcinoma Jennifer Chuy   
A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use (SIMPLIFY) Alain Litwin, MD   
A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor (NEWBORN-1) Ashlesha Dayal, MD   
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer Benjamin Gartrell, MD   
A Phase III Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination With Carboplatin + Paclitaxel With or Without Bevacizumab in Patients With Stage IV Non-squamous Non-small Cell Lung Cancer [IMpower 150] Haiying Cheng, MD   
A Phase III Study of Pembrolizumab (MK-3475) vs. Best Supportive Care as Second-Line Therapy in Subjects with Previously Systemically Treated Advanced HepatocellularCarcinoma (KEYNOTE-240) Andreas Kaubisch   
A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (KEYNOTE-177) Lakshmi Rajdev   
A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN- (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive, Non-Muscle Invasive Bladder Cancer (NMIBC). Alexander I. Sankin   
A Phase WW Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody Ch14.18 (Dinutuximab, NSC764038, IND 4308) in Combination with Sargramostim (GM-CSF) in Patients with Recurrent Osteosarcoma. Lisa Figueiredo   
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer Madhur Garg   
A program of enhanced recovery after cesarean birth to improve postoperative recovery and reduce hospital length of stay Peter Bernstein   
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome John Thompson, MD   
A PROspective, Observational, US-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated With Valchlor® Holly Kanavy, DO   
A prospective, open label Phase I/II study to assess the safety and efficacy of cycles of intravenously infused doses of OPN-305 in second-line lower (Low and intermediate-1) risk myelodysplastic syndrome (MDS) Aditi Shastri   
A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PHASE 3 STUDY TO ASSESS THE SAFETY AND EFFICACY OF INTRAVENOUS CEFTOLOZANE/TAZOBACTAM COMPARED WITH MEROPENEM IN ADULT PATIENTS WITH VENTILATED NOSOCOMIAL PNEUMONIA Paul Riska   
A Randomized Phase 2 Study of Abemaciclib (LY2835219) versus Docetaxel in Patients with Stage IV Squamous Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy Balazs Halmos   
A randomized Phase II trial of Fulvestrant with or without Ribociclib (LEE011) after progression on aromatase inhibition plus cyclin-dependent kinase 4/6 inhibition in patients with advanced hormone receptor positive, HER2 negative breast cancer Sun Young Oh   
A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) Benjamin Gartrell, MD    
A Randomized Trial to Assess Patient Quality of Life and Function after Alternative Surgeries for Pathologic Fractures of the Femur Rui Yang   
A Randomized, Double-Blind, Phase III Study of Carboplatin-Paclitaxel/Nab-PaclitaxelChemotherapy with or without Pembrolizumab (MK-3475) in First Line Metastatic Squamous Non-small Cell Lung Cancer Subjects (KEYNOTE-407) Balazs Halmos   
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder. Eric Hollander   
A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD) Kristina Chacko, MD   
A Randomized, Open-label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD- in Subjects with Alcohol-Induced Liver Decompensation (AILD) Kristina Chacko   
A randomized, open-label, multicenter, phase 3 study to evaluate the efficacy and safety of Avelumab (MSB0010718C) in combination with and/or following chemotherapy in patients with previously untreated epithelial ovarian cancer Akiva Novetsky   
A randomized, open-label, multicenter, two arm, phase IIstudy to evaluate treatment compliance, efficacy and safety of an improved deferasirox formulation (granules) in pediatric patients with iron overload Deepa Manwani   
A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib NSC 761968, Crizotinib NSC 749005, Savolitinib NSC 785348, and Sunitinib NSC 736511) in Metastatic Papillary Renal Carcinoma (PAPMET) Benjamin Gartrell   
A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA) (AIHA) Irina Murakhovskaya, MD   
A Safety and Pharmacology Study of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) Administered Alone or in Combination With Azacitidine in Patients With Myelodysplastic Syndromes Amit Verma, MD   
A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA (BORA) Golda Hudes, MD   
A Single Arm Phase IV Study of Afatinib in Elderly Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Whose Tumors Have Epidermal Growth Factor Receptor (EGFR) Exon 19 Deletions or Exon 21(L858R) Substitution Mutations Balazs Halmos, MD   
A Study Looking at Targeted Therapy According to Tumor Markers for People With Meningiomas Nitin Ohri, MD   
A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer Balazs Halmos, MD   
A Study of Atezolizumab (MPDL3280A) in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Patients With Previously Untreated Metastatic Triple Negative Breast Cancer (IMpassion130) Joseph Sparano, MD   
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting Mark Schoenberg, MD   
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting Mark Schoenberg   
A Study of Cobimetinib in Combination With Paclitaxel as First-line Treatment for Patients With Metastatic Triple-negative Breast Cancer Joseph Sparano, MD   
A Study of GC4419 Protection Against Radiation Induced Oral Mucositis in Patients With Head & Neck Cancer Madhur Garg, MD   
A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MEDALIST) Amit Verma, MD   
A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL Murali Janakiram, MD   
A Study of LY3039478 in Participants With Advanced Cancer Sanjay Goel, MD   
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) Balazs Halmos   
A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer Jennifer Chuy, MD   
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) (VICTORIA) Sandhya Murthy   
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) (VICTORIA) Sandhya Murthy, MD   
A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer (PREDICT) Benjamin Gartrell, MD    
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) Della Makower, MD    
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants Ramakrishna Battini, MD   
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UNIFI) Dana Lukin, MD   
A011106 ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women a phase III study Della Makower   
A011502 A randomized phase III double blinded placebo-controlled trial of aspirin as adjuvant therapy for node-positive, HER2 negative breast cancer the ABC trial Della Makower   
A071102 A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with MGMT Promoter Hypermethylation Nitin Ohri   
A081105 Randomized Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) Haiying Cheng   
A221405 A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer who Desire Pregnancy Joseph Sparano   
Acetaminophen 1g IV vs Hydromorphone 1mg IV for the Treatment of Acute Pain in the Emergency Department Douglas Barnaby   
ACTH for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome Kimberly Reidy, MD   
Active commuting to school and behavior problems among school-aged children Ruth Stein, MD   
Acupuncture Approaches to Decrease Disparities in Outcomes of Pain Treatment - A Two Arm Comparative Effectiveness Trial Melissa Mckee   
Acute Kidney Injury in Children with Acute Respiratory Failure Scott Aydin, MD   
Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery Madhur Garg, MD   
Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients (ATLAS) Benjamin Gartrell, MD   
Adult Congenital Heart Disease Registry (QuERI) Ali Zaidi, MD   
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer Sanjay Goel, MD   
Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma Noah Kornblum, MD   
An Early Phase 1 Study of ABT-888 in Combination with Carboplatin and Paclitaxel in Patients with Hepatic or Renal Dysfunction and Solid Tumors (NCI 8808) Sanjay Goel   
An Efficacy and Safety Study of JNJ-56021927 (ARN-509) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS Benjamin Gartrell, MD    
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease Kris Mahadeo   
An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors (RIFTOS MKI) Missak Haigentz, MD   
An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants (SENTINEL1) Iona Munjal, MD   
An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patient Populations Diagnosed With Early-Onset Idiopathic Bilateral Cataracts Norman Medow, MD   
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Sanjay Goel, MD    
An open label phase II study to evaluate the efficacy andsafety of PDR001 in patients with advanced or metastaticnon-functional neuroendocrine tumors of pancreatic,gastrointestinal (GI), or thoracic origin who haveprogressed on prior treatment Edward Michael Wolin   
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures Alexis Boro   
An Open Label, Phase Ia/Ib Trial of the DNA-PKInhibitor MSC2490484A in Combination withRadiotherapy in Patients with Advanced Solid Tumors Sanjay Goel   
Analysis of Clinical and Laboratory Measures in Children with Intestinal Failure at the Children's Hospital at Montefiore John Thompson, MD   
ANCHOR (Aneurysm Treatment Using the HeliFX Aortic Securement System Global Registry) Evan Lipsitz, MD   
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study (INSIGHT 006 FLU-IVIG) Paul Riska   
Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy (AXAFA) Luigi Di Biase, MD, PhD   
ARCHIVE: A registry for children with vasculitis: e-entry Dawn Wahezi, MD   
Are children with Autistic Spectrum Disorder diagnosed before 2 years of age different clinically from older children diagnosed after 2 years of age? Maria Valicenti-McDermott, MD    
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma Nitin Ohri, MD   
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Peter Cole, MD   
Astagraf XL- to Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation Enver Akalin   
Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry Frederick Kaskel, MD   
Autism Genetics Network, Phase II: Increasing Representation of Human Diversity Sophie Molholm, PhD   
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor) Sanjay Goel   
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor) Sanjay Goel, MD   
Azithromycin for Children Hospitalized With Asthma Lindsey Douglas, MD   
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction Sanjay Goel, MD   
Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia (BEST-CLI) Evan Lipsitz, MD   
BETA ADRENERGIC RECEPTOR BLOCKADE AS A NOVEL THERAPY FOR PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE Benjamin Gartrell   
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors Mary Welch, MD    
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (ATLAS) Chaim Putterman, MD   
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Jonathan Gill, MD   
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia Jonathan Gill, MD   
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Jonathan Gill, MD   
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Peter Cole, MD   
Breast Cancer WEight Loss Study (BWEL Study) Della Makower, MD    
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma Murali Janakiram, MD    
Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma Jonathan Gill, MD   
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma Peter Cole, MD   
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Peter Cole, MD   
Buprenorphine group medical visits for drug users at risk for HIV Aaron Fox   
Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus Jennifer Chuy, MD   
Cardiovascular Inflammation Reduction Trial (CIRT) Anna Bortnick, MD   
Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants Akiva Novetsky, MD   
Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy Peter Cole, MD   
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Jonathan Gill, MD   
Central Mechanisms That Regulate Glucose Metabolism in Humans Meredith Hawkins   
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma Jonathan Gill, MD   
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer Joseph Sparano, MD   
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer Benjamin Gartrell, MD    
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Jonathan Gill, MD   
Clinical characterization of the pre-ictal state in the pediatric population: A caretaker's perspective on seizure prediction Sheryl Haut, MD   
Clinical Study of the Reversal of Anticoagulant Effects of Dabigatran by Intravenous Administration of 5.0g Idarucizumab (BI 655075) in Patients Treated Wtih Dabigatran Etexilate Who Have Uncontrolled Bleeding or Require Emergency Surgery or Procedures Kevin Ferrick, MD   
Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation (Soprano) Ulrich Jorde, MD   
COG-AALL0932 Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy) Lisa Figueiredo   
COG-AALL1131 A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND 73789, NSC 606869) in the Very High Risk Stratum Lisa Figueiredo   
COG-AAML1031 A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND114480 NSC 681239, NSC 724772) for Patients with High Allelic Ratio FLT3/ITD Lisa Figueiredo   
COG-ACCL1033 A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL Lisa Figueiredo   
COG-AEWS1031 A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma Lisa Figueiredo   
COG-ANBL1221 A Phase II Randomized Trial of Irinotecan/Temozolomide with Temsirolimus (NSC 683864, IND 61010) or Chimeric 14.18 Antibody (ch14.18) (NSC 623408, IND 4308) in Children with Refractory, Relapsed or Progressive Neuroblastoma Lisa Figueiredo   
COG-ANBL1232 Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma Lisa Figueiredo   
COG-ANHL12P1 A Randomized Phase II study of Brentuximab Vedotin (NSC 749710) and Crizotinib (NSC 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL) IND 117117 Jonathan Gill   
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Peter Cole, MD   
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Jonathan Gill, MD   
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Jonathan Gill, MD   
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Peter Cole, MD   
Collecting and Storing Tissue From Young Patients With Cancer Peter Cole, MD   
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Peter Cole, MD   
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Jonathan Gill, MD   
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies Missak Haigentz, MD    
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia Peter Cole, MD   
Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma Jonathan Gill, MD   
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Olga Derman, MD   
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Jonathan Gill, MD   
Combination Chemotherapy, Gemcitabine Hydrochloride, and Radiation Therapy Before Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer Jennifer Chuy, MD   
COMMUNITY CENTRAL LINE INFECTION PREVENTION (CCLIP) Trial Jennifer Davila   
Comparative Effectiveness of Pregnancy Failure Management Regimens (PreFaiR) Jessica Atrio, MD   
Compared Outcomes of Closed Reduction in the Emergency Room Versus the Operating Room in the Treatment of Pediatric Supracondylar Humerus Fractures Jacob Schulz, MD   
Comparison of menstrual patterns and ovarian reserve in adolescent girls with systemic lupus erythematosus, juvenile idiopathic arthritis, and girls without chronic illness Dawn Wahezi, MD   
comParIson Of Sacubitril/valsartaN Versus Enalapril on Effect on ntpRo-bnp in Patients Stabilized From an Acute Heart Failure Episode (PIONEER-HF) James Tauras   
Complete vs Culprit-only Revascularization to Treat Multi-vessel Disease After Primary PCI for STEMI (COMPLETE) Mark Menegus, MD   
Connect® MM- The Multiple Myeloma Disease Registry Fernando Camacho, MD   
Consideration of Pedicle Screw Misplacement on a Per-Patient Basis: Can we Better Delineate Surgical Risk? Vishal Sarwahi, MD   
CORRONA Data Collection Program Anna Broder, MD   
Corticosteroids for Acute Migraine in the Emergency Department Benjamin Friedman   
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) Steven Keller, MD   
CureGN: Cure Glomerulonephropathy Network Frederick Kaskel, MD   
Defensin and Innate Immunity Gitit Tomer, MD   
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma Jonathan Gill, MD   
Desmopressin as a Therapy for Nocturnal Enuresis in Patients with Sickle Cell Disease Kerry Morrone   
Determining the Natural and "Unnatural" History of Anomalous Aortic Origin of a Coronary Artery with an Interarterial Course (AAOCA): Establishing a Multi-Institutional Registry Daphne Hsu, MD   
Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyopathy (NICMR) Mario Garcia, MD   
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma Jonathan Gill, MD   
Does Pedicle Morphology Change with Age? Vishal Sarwahi, MD   
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Madhur Garg, MD   
Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer Sanjay Goel, MD   
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Della Makower, MD    
Drug Challenges without Prior Skin Testing Elina Jerschow   
DryShield vs Cotton Roll Isolation during Sealants Placement: Efficiency and Patient Preference Nuntiya Kakanantadilok   
E1Z11 A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) Della Makower   
E2112 A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Men and Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer Della Makower   
E3311 Phase II Randomized Trial of Transoral Surgical Resection followed by Low-dose or Standard-dose IMRT in Resectable p16 Locally Advanced Oropharynx Cancer Richard Smith   
E3A06, Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma Murali Janakiram   
E7208 A Randomized Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild-type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy Sanjay Goel   
EA1141, Comparison of Abbreviated Breast MRI and Digital Breast Tomosynthesis in Breast Cancer Screening in Women with Dense Breasts Beatriu Reig   
Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants Mamta Fuloria, MD   
Effect of resveratrol on age-related insulin resistance and inflammation in humans Meredith Hawkins   
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease (MAPUS) Lawrence Brandt, MD   
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension Anurag Shrivastava, MD   
Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumors (SPINET) Edward Wolin, MD   
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction (PARAGON-HF) Ileana Piña, MD, MPH   
Efficacy of a DVD Intervention for Latina Breast Cancer Survivors David Lounsbury, PhD   
Efficacy of Group Attachment Based Intervention for Vulnerable Families Anne Murphy, PhD   
Efficacy, Safety And Tolerability Of Tofacitinib For Treatment Of Polyarticular Course Juvenile Idiopathic Arthritis (JIA) In Children And Adolescent Subjects Norman Ilowite, MD   
EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FORTREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHICARTHRITIS (JIA) IN CHILDREN AND ADOLESCENT SUBJECTS Dawn Wahezi   
Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery Boleslav Kosharskyy   
Efficacy, Safety, Tolerability of Carbavance Compared to Best Available Therapy in Serious Infections Due to Carbapenem Resistant Enterobacteriaceae, in Adults Paul Riska, MD   
Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients Marina Reznik   
Electrophysiologic Indices of Acoustic Processing Deficits Among Childhood Cancer Survivors Peter Cole, MD   
EmricasaN, a Caspase inhibitOR, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis (ENCORE-NF) (ENCORE-NF) Harmit Kalia, DO   
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group Jonathan Gill, MD   
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer Benjamin Gartrell, MD    
Epigenetic and Developmental Effects of In Utero Exposure to Environmental Toxicants Mamta Fuloria, MD   
EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures (EPVent2) Michelle Gong, MD   
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer (EVENT) Haiying Cheng, MD   
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) Steven Keller, MD   
EVALUATING THE BENEFIT OF CONCURRENT TRICUSPID VALVE REPAIR DURING MITRAL SURGERY Robert Michler   
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Nicole Nevadunsky, MD   
Evaluation of CYP2D6 genetic polymorphisms in a diverse urban population TJ Ow, MD    
Evaluation of the Rate of Discordance between Thiopurine Methyltransferase Phenotype and Genotype in Pediatric Patients with Gastrointestinal Disease Inna Novak, MD   
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery Steven Libutti, MD    
Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic Della Makower, MD    
Expanded Access Protocol for Therapeutic Use of 177Lu-DOTA0-Tyr3-Octreotate in Patients With Inoperable, Somatostatin Receptor Positive, Midgut Carcinoid Tumors, Progressive Under Somatostatin Analogue Therapy Edward Wolin, MD   
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer Sanjay Goel, MD   
Exploring Brain Responses to Affective Images in Mothers with High or Low Adverse Childhood Experiences (Aces) Anne Murphy, PhD   
Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Lawrence Brandt, MD    
FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer (FLT3) Nitin Ohri, MD   
Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer Joseph Sparano, MD   
Follow-up study of children with early diagnosis of autism spectrum disorder Lisa Shulman, MD   
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery Della Makower, MD    
Gene Discoveries in Subjects with Crohns Disease of African Descent Gitit Tomer, MD   
Genetic Predisposition to Appendicitis: A Pilot Study Dominique Jan, MD   
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) Steven Keller, MD   
Genomic Response Analysis of Heart Failure Therapy in African Americans (GRAHF-2) James Tauras, MD   
Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma Jonathan Gill, MD   
HEALTHCALL ENHANCING BRIEF INTERVENTION FOR HIV PRIMARY CARE ALCOHOL DEPENDENCE Barry Zingman   
Heart And Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT) Shivanand Medar, MD    
High Risk Multiple Gestation Study Peer Dar, MD   
Ibuprofen Plus Metaxolone, Tizanidine, or Baclofen for Low Back Pain Benjamin Friedman   
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis Madhur Garg, MD   
Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study (IDEAS) Jessica Zwerling, MD   
Immediate postpartum contraceptive implant placement and breastfeeding success in women at risk for low milk supply a randomized non-inferiority trial Erika Levi   
Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Amit Verma, MD   
Improving a Bayesian Model Survival in Patient Needing Surgery for Bone Metastases Rui Yang   
Improving Pediatric Transport to the Children's Hospital at Montefiore Chhavi Katyal, MD   
Infantile Spasms Multicenter Database Elissa Yozawitz, MD   
Inhaled Azacitidine in Patients With Advanced Non-small Cell Lung Cancer Roman Perez-Soler, MD   
Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers Study (INSIGHTS Study) Caterina Minniti, MD   
International Guillain-Barré Syndrome Outcome Study (IGOS) Volkan Granit, MD   
International Registry for Severe Chronic Neutropenia Kerry Morrone, MD   
Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter Peter Muscarella, MD   
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial Rishi Malhotra, MD   
Intravenous Gammaglobulin for Sickle Cell Pain Crises Deepa Manwani, MD   
Ischemia Care Biomarkers of Acute Stroke Etiology (BASE) Mellanie Springer, MD   
IV Acetaminophen as an Analgesic Adjunct Douglas Barnaby   
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects Giles Peek   
LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT-SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TOPULMONARY VEIN ISOLATION FOR PERSISTENT ORLONGSTANDING PERSISTENT ATRIAL FIBRILLATION Luigi Di Biase   
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Murali Janakiram, MD   
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Jonathan Gill, MD   
Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis Holly Kanavy, DO   
Long-Term Clinical and Radiologic Outcomes of Patients Treated At a Single Institution For Slipped Capital Femoral Epiphysis Jacob Schulz, MD   
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Jonathan Gill, MD   
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis Norman Ilowite, MD   
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens Heather Smith, MD   
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers Golda Hudes, MD   
Lung Cancer Information Study (LCIS-R01) Richard Gralla, MD   
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Haiying Cheng, MD   
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma Jonathan Gill, MD   
Mechanisms of Hypoglycemia Associated Autonomic Failure Meredith Hawkins   
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases William Bodner, MD   
Metformin in Children With Relapsed or Refractory Solid Tumors Jonathan Gill, MD   
Metoclopramide for post-traumatic headache. A pilot study Benjamin Friedman   
Mifepristone Induction for Fetal Demise (MIFD) Jessica Atrio, MD   
Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III (MISTIE III) Rishi Malhotra, MD   
Molecular and Genomic Profiling of Head and Neck Tumors Richard Smith, MD   
Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF) Swati Goel, MD   
Mood disorder and cognitive dysfunction in pediatric lupus Chaim Putterman, MD   
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer Beatriu Reig, MD    
Multicenter Expanded Access Protocol of Allogeneic Epstein-Barr Virus Cytotoxic T Lymphocytes (EBV-CTLs) for Patients with EBV-Associated Viremia or Malignancies for Whom there are No Appropriate Alternative Therapies Lisa Figueiredo   
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease (IPSG1) Eric Fornari, MD   
Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors Sanjay Goel, MD   
Myocardial Ischemia and Transfusion Mark Menegus   
Natural History Study of the Development of Type 1 Diabetes Rubina Heptulla, MD   
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas Balazs Halmos, MD   
Nephrotic Syndrome Study Network (NEPTUNE) Frederick Kaskel, MD   
Neurocognitive Effects of Opiate Agonist Treatment (NEO) Julia Arnsten, MD   
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Jonathan Gill, MD   
Nivolumab and Ipilimumab in Treating Patients With Advanced HIV Associated Solid Tumors Lakshmi Rajdev, MD   
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) Arye Rubinstein, MD   
North American Pediatric Renal Trials and Collaborative Studies Marcela Del Rio, MD   
NRG-GI002 A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer Rafi Kabarriti   
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) (TRUMPET) Benjamin Gartrell, MD    
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry Yonit Sterba Ruas, MD   
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer (OlympiA) Jesus Anampa Mesias, MD    
Open-Label Safety Trial of Intravenous Neridronic Acid in Subjects with Complex Regional Pain Syndrome (CRPS) Naum Shaparin   
Open-label Study to Assess the Long-term Safety and Efficacy of Momelotinib in Subjects with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essentialThrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia Swati Goel   
Outcomes of coronary artery aneurysms after Kawasaki disease:An international multicentre registry Nadine Choueiter, MD   
Outcomes of Neonatal Acute Kidney Injury In Premature Infants Mamta Fuloria, MD   
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome (OXT-PWS) Eric Hollander, MD   
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer Marina Frimer, MD   
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies Nicole Nevadunsky, MD   
Parental Understanding of an In-Toeing Gait Jacob Schulz, MD   
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Benjamin Gartrell, MD    
Ped Cardiac Quality of LIfe Jacqueline Lamour, MD   
Pediatric Airway Database: An Observational Trial John Bent, MD   
Pediatric Appropriate Use Criteria Implementation Project: An Outpatient Echocardiography Quality Initiative Kenan Stern, MD   
Pediatric Heart Transplant Study Group Jacqueline Lamour, MD   
Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy (PLUTO) Dawn Wahezi, MD   
Personalized Medicine: Pediatric Total Cancer Care™ Protocol Jonathan Gill, MD   
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC) Sanjay Goel   
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC) Sanjay Goel, MD   
Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure (RELAX-PEDS-PK) Daphne Hsu, MD   
Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid Tumors Sanjay Goel, MD   
Phase 1/2, First-in-Human, Dose-Escalation Study of X-396 in Patients With Advanced Solid Tumors and Expansion Phase in Patients With ALK-positive Non-Small Cell Lung Cancer Haiying Cheng, MD   
Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) (LAPACT) Jennifer Chuy, MD   
Phase 2 Open-Label Extension Study Investigating the Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum Steven Cohen   
Phase 2 Study of Denosumab (IND 127430, NSC 744010), a Rank Ligand Antibody, for Recurrent or Refractory Osteosarcoma Lisa Figueiredo   
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET Balazs Halmos, MD   
Phase 2 trial of Gamunex (Intravenous Gamma globulin) for Sickle Cell Acute Pain Deepa Manwani   
Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 20 mg or 14 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Missak Haigentz, MD   
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer Sanjay Goel, MD   
PHASE 3 STUDY OF IV TO ORAL 6-DAY TEDIZOLID PHOSPHATE COMPARED WITH 10-DAY COMPARATOR IN SUBJECTS 12 TO David Goldman   
Phase I Pharmacokinetic Study of Belinostat for Solid Tumors and Lymphomas in Patients with Varying Degrees of Hepatic Dysfunction (NCI 8846) Sanjay Goel   
Phase I/II study of CaspaCide T cells from an HLA-partially matched family donor after negative selection of TCR a-T cells in pediatric patients affected by hematological disorders Deepa Manwani   
Phase I/II Trial of Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer Della Makower, MD    
Phase I/II, First-in-Human, Dose-Escalation Study of X-396 in Patients with Advanced Solid Tumors and Expansion Phase in Patients with ALK Non-Small Cell Lung Cancer Haiying Cheng   
Phase II Study of Lenalidomide and Eltrombopag in Patients with Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome Amit Verma, MD   
Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome (MDS) Amit Verma   
Phase II Trial of Rituximab In Myasthenia Gravis Volkan Granit, MD    
Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer (VIABLE) Benjamin Gartrell, MD    
PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL-GROUP, STUDY OF AB103 AS COMPARED TO PLACEBO IN PATIENTS WITH NECROTIZING SOFT TISSUE INFECTIONS (NSTI) Vance Smith   
Pilot Study of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients with Recurrent Malignant Neuro-Epithelial Tumors or Without Suitable Autologous Hematopoietic Progenitor Cell Availability Kris Mahadeo, MD   
Platinum Based Chemotherapy or Observation in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy Joseph Sparano, MD   
Postadenoidectomy analgesic effects of intraoperative intravenous dexamethasone in children Ngoc Nguyen, MD   
Predischarge Initiation of Ivabradine in the Management of Heart failure Ileana Pina   
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer (POSITIVE) Joseph Sparano, MD   
Prematurity and Respiratory Outcomes Program (PROP) Judy Aschner, MD   
PREVENTion of Non-Surgical Bleeding by Management of HeartMate II Patients without Antiplatelet Therapy Omar Saeed   
Prevention of Severe Acute Respiratory Failure in Patients With PROOFCheck (PROOFcheck) Michelle Gong, MD   
Profiling Actionable Genetic Alterations in Pediatric Tumors: The Children's Hospital at Montefiore Protocol for Screening Pediatric Tumors to Define Genetic Alterations Adam Levy, MD   
Project: Every Child for Younger Patients With Cancer Jonathan Gill, MD   
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) David Geller, MD   
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Rebecca Levine, MD    
Prospective Research Database for Pediatric Patients with Spinal Deformity Vishal Sarwahi, MD   
Prospective Scoliosis Outcomes Database Jacob Schulz, MD   
Prospective, Multi Centre, International Registry of Male and Female Patients Newly Diagnosed With Atrial Fibrillation Kevin Ferrick, MD   
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries Ira Braunschweig, MD   
Protocol for a Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation Ira Braunschweig, MD    
Quarenta Semanas: Innovative Intervention in Prenatal Care for Reduction of Prematurity (quarenta) Judy Aschner, MD   
Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With High-risk Endometrial Cancer Dennis Kuo, MD   
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery Gary Goldberg, MD   
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can be Removed by Surgery (PAZNTIS) Jonathan Gill, MD   
Radiofrequency Energy Delivery to the Lower Esophageal Sphincter (Stretta) in Sleeve Gastrectomy Patients With GERD Erin Moran-Atkin, MD   
Randomized On-X Anticoagulation Trial Ricardo Bello, MD   
RANDOMIZED PHASE II EVALUATION OF CARBOPLATIN/PACLITAXEL WITH AND WITHOUT TRASTUZUMAB (HERCEPTIN) IN HER2/neu PATIENTS WITH ADVANCED/RECURRENT UTERINE SEROUS PAPILLARY CARCINOMA Nicole Nevadunsky   
Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC 750008, IND 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma Lisa Figueiredo   
Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer Jesus Anampa Mesias, MD   
Reevaluation Of Systemic Early Neuromuscular Blockade (ROSE) Michelle Gong, MD   
Remission From Stage D Heart Failure (RESTAGE-HF) Snehal R. Patel, MD   
Renal Biomarkers in Pediatric Acute Decompensated Heart Failure Scott Aydin, MD   
Reproductive Health Program in Patients With Cancer Della Makower, MD    
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma Peter Cole, MD   
Restorelle® Mesh Versus Native Tissue Repair for Prolapse Keith Downing, MD    
Retrospective Evaluation of Sedation Efficacy for Magnetic Resonance Imaging in Pediatric Patients: Dexmedetomidine versus Propofol. Chhavi Katyal, MD   
Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia Peter Cole, MD   
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Peter Cole, MD   
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Jonathan Gill, MD   
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma Aditi Shastri, MD   
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3) Della Makower   
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3) Della Makower, MD    
S1216A Phase III Randomized Trial Comparing Androgen Deprivation Therapy TAK-700 With Androgen Deprivation Therapy Bicalutamide in Patients With Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer Benjamin Gartrell   
S1314, A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer Benjamin Gartrell   
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer (COXEN) Benjamin Gartrell, MD    
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Lakshmi Rajdev, MD   
Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients Daniel Goldstein, MD   
Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry (SABLE) Chaim Putterman, MD   
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (OPTIMISMM) Murali Janakiram, MD   
Safety and Efficacy of Switching to a FDC of GS-9883/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women Robert Grossberg, MD   
Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer (aboundsqm) Haiying Cheng, MD   
Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (ASPECT-NP) Paul Riska, MD   
Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery Stuart Greenstein, MD   
Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002) Marla Keller, MD   
Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer Sun Young Oh   
SAFETY EFFICACY OF INTRAMYOCARDIAL INJECTION OF MESENCHYMAL PRECURSOR CELLS ON MYOCARDIAL FUNCTION IN LVAD RECIPIENTS Daniel Goldstein   
Safety Follow-up of Treatment With Remestemcel-L in Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD Kris Mahadeo, MD   
Safety Follow-up Through 180 Days of Treatment withRemestemcel-L in Study MSB-GVHD001 in Pediatric Patients who have Failed to Respond to Steroid Treatment for Acute GVHD Deepa Manwani   
Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome Amit Verma, MD   
Safety Study of ALRN-6924 in Patients With Advanced Solid Tumors Sanjay Goel, MD   
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant Kris Mahadeo, MD   
Self regulation in children with learning disabilities and inattention/hyperactivity Katherine Lawson, PhD   
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness Sophie Molholm, PhD   
Sentus QP - Extended CRT Evaluation with Quadripolar Left Ventricular Leads Nils Guttenplan   
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads (QP ExCELs) Nils Guttenplan, MD   
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition John Thompson, MD   
SILVER-AMI: Outcomes in Older Persons With Heart Attacks Cynthia Taub, MD   
SINGLE ARM STUDY OF ALXN1210 IN COMPLEMENT INHIBITOR TREATMENT-NA-VE ADULT AND ADOLESCENT PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) Irina Murakhovskaya   
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C Haejin In, MD   
SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission Ioannis Mantzaris, MD   
SNP-based Microdeletion and Aneuploidy RegisTry (SMART) Peer Dar, MD   
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer Nitin Ohri, MD   
Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer Jana Fox, MD   
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Jana Fox, MD   
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer Nitin Ohri, MD   
Study of Acarbose in Longevity Erika Brutsaert   
Study of Kidney Tumors in Young Patients Jonathan Gill, MD   
Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer Sanjay Goel, MD   
Study of Tedizolid Phosphate (TZD) in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012) Iona Munjal, MD   
Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia Scott Aydin,MD   
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] Steven Keller, MD   
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) Balazs Halmos   
Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor Swati Goel, MD   
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters Alexis Boro, MD   
Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters (ARTEMIS1) Alexis Boro, MD   
Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload Deepa Manwani, MD   
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Mary Welch, MD   
The ASTHMA-Educator: A novel Algorithmic Software Tool in the Healthcare system for Managing Asthma Sunit P. Jariwala, MD   
The Children’s Spine Registry Jaime Gomez, MD   
The Chimerix CMX001 Registry Olga Derman, MD   
The National Emergency Airway Registry for Children Michael Miksa, MD   
The Pediatric Diabetes Consortium (PDC): Type 2 Diabetes in Youth Registry Rubina Heptulla, MD   
The Reliability of X-Ray Based Evaluation of Pedicle Screw Misplacement in Adolescent Spinal Deformity Vishal Sarwahi, MD   
The Serial Neurocognitive Screening of Children and Adolescents During Treatment for Acute Lymphoblastic Leukemia (ALL) on the Dan Farber Cancer Institute ALL Consortium Study 11-001 Peter Cole, MD   
The use of Complementary and Alternative Medicine in Autism Maria Valicenti-McDermott, MD    
The use of Virtual Reality Games to Enhance Therapy for Children with Cerebral Palsy. A pilot Study Maria Valicenti-McDermott, MD    
Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ IDE Clinical Study Protocol Daniel Goldstein, MD    
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect (TRIPLE) John Hardin   
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions (ANCHOR) Rebecca Levine, MD   
Transfusion Requirements in Cardiac Surgery III (TRICS-III) Jonathan Leff, MD    
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Missak Haigentz, MD   
Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy Michael Thorpy, MD   
Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" (OSA) Michael Thorpy, MD   
US-based, Observational, Drug Registry of Opsumit® (Macitentan) New Users in Clinical Practice Ali Zaidi, MD   
Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Gloria Huang, MD   
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Sanjay Goel, MD   
Vertical Expandable Prosthetic Titanium Rib (VEPTR) - (Humanitarian Project) Vishal Sarwahi, MD   
Vest prevention of Early Sudden death Trial (VEST) Jay Gross, MD   
Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG Alexander I. Sankin   
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder Eric Hollander, MD   
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer William Bodner, MD